Catalyst Wire Dossier Catalyst Wire Dossier

Rabies mAb CBB-1 Combination Vaccine

CBB-1 Rabies Monoclonal Antibody Combination Vaccine · Changchun BCHT Biotechnology Co.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Rabies mAb CBB-1 Combination Vaccine, covering 2024-08-12 to 2024-08-12. Get the full timeline:

Most recent: Clinical Trial Update: Rabies mAb CBB 1 Combination Vaccine in Healthy People With Antibody Neutralization Activity and Safety Phase Clinical Trials [Phase 2]

See pricing